| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.06 |